Global Bioinformatics Partnering Terms and Agreements 2014 to 2020

$3,495.00

The Global Bioinformatics Partnering Terms and Agreements 2014 to 2020 report provides comprehensive understanding and unprecedented access to the bioinformatics partnering deals and agreements entered into by the worlds leading healthcare companies.

Publication date
June 2020
Number of pages
600+
Product type
Research report
Available formats
PDF document
Report edition
2
SKU
CP2111

The Global Bioinformatics Partnering Terms and Agreements 2014 to 2020 report provides comprehensive understanding and unprecedented access to the bioinformatics partnering deals and agreements entered into by the worlds leading healthcare companies.

 

  • Trends in bioinformatics partnering deals
  • Deal terms analysis
  • Partnering agreement structure
  • Partnering contract documents
  • Top deals by value
  • Most active deal makers
  • Financial deal terms for bioinformatics

 

The Global Bioinformatics Partnering Terms and Agreements 2014 to 2020 report provides comprehensive understanding and unprecedented access to the bioinformatics partnering deals and agreements entered into by the worlds leading healthcare companies.

 

The report provides a detailed understanding and analysis of how and why companies enter bioinformatics partnering deals. The majority of deals are discovery stage whereby the licensee obtains a right or an option right to license the licensors bioinformatics technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

 

This report provides details of the latest bioinformatics agreements announced in the healthcare sectors.

 

Bioinformatics is the application of computer science and information technology to the field of biology and medicine. Bioinformatics deals with algorithms, databases, information systems, web technologies, artificial intelligence, information and computation theory, software engineering, data mining, image processing, modeling, simulation, signal processing, discrete mathematics, control systems, and statistics, for generating new knowledge of biology and medicine.

 

Bioinformatics deals have increased in terms of popularity for partnering in the past decade, as computing power has been embraced in order to speed up the discovery, evaluation and clinical assessment processes.

 

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.

 

This report contains a comprehensive listing of all bioinformatics partnering deals announced since January 2014, including financial terms where available, including over 1200 links to online deal records of actual bioinformatics partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.

 

The initial chapters of this report provide an orientation of bioinformatics dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in bioinformatics dealmaking since 2014, including details of average headline, upfront, milestone and royalty terms.

                    

Chapter 3 provides a review of the leading bioinformatics deals since 2014. Deals are listed by headline value, signed by big pharma, most active bioinformatics dealmaking companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

                                           

Chapter 4 provides a comprehensive listing of the top 25 most active companies in bioinformatics dealmaking with a brief summary followed by a comprehensive listing of bioinformatics deals, as well as contract documents available in the public domain. Where available, each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.

 

Chapter 5 provides a comprehensive and detailed review of bioinformatics partnering deals signed and announced since January 2014, where a contract document is available in the public domain.Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

 

Chapter 6 provides a comprehensive and detailed review of bioinformatics partnering deals signed and announced since Janunary 2014. The chapter is organized by specific bioinformatics technology type in focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

 

In addition, a comprehensive appendix is provided organized by bioinformatics partnering company A-Z, deal type definitions and bioinformatics partnering agreements example. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

 

The report also includes numerous tables and figures that illustrate the trends and activities in bioinformatics partnering and dealmaking since 2014.

                                                  

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of bioinformatics technologies and products.

 

Bioinformatics Partnering Terms and Agreements provides the reader with the following key benefits:

 

• In-depth understanding of bioinformatics deal trends since 2014

• Access to headline, upfront, milestone and royalty data

• Analysis of the structure of bioinformatics agreements with numerous real life case studies

• Comprehensive access to over 1200 bioinformatics deals entered into by the world’s biopharma companies

• Detailed access to actual bioinformatics contracts enter into by the leading bigpharma companies

• Insight into the terms included in a bioinformatics agreement, together with real world clause examples

• Understand the key deal terms companies have agreed in previous deals

• Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Bioinformatics Partnering Terms and Agreements provides the reader with the following key benefits:

 

  • In-depth understanding of bioinformatics deal trends since 2014
  • Access to headline, upfront, milestone and royalty data
  • Analysis of the structure of bioinformatics agreements with numerous real life case studies
  • Comprehensive access to over 1200 bioinformatics deal documents entered into by the world’s biopharma companies
  • Detailed access to actual bioinformatics contracts 
  • Insight into the terms included in a bioinformatics agreement, together with real world clause examples
  • Understand the key deal terms companies have agreed in previous deals
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Executive Summary

 

Chapter 1 – Introduction

 

Chapter 2 – Trends in bioinformatics dealmaking

 

2.1. Introduction
2.2. Bioinformatics partnering over the years
2.3. Most active bioinformatics dealmakers
2.4. Bioinformatics partnering by deal type
2.5. Bioinformatics partnering by therapy area

2.6. Deal terms for bioinformatics partnering

2.6.1 Bioinformatics partnering headline values
2.6.2 Bioinformatics deal upfront payments
2.6.3 Bioinformatics deal milestone payments
2.6.4 Bioinformatics royalty rates

 

Chapter 3 – Leading bioinformatics deals

 

3.1. Introduction
3.2. Top bioinformatics deals by value

 

Chapter 4 – Most active bioinformatics dealmakers

 

4.1. Introduction
4.2. Most active bioinformatics dealmakers
4.3. Most active bioinformatics partnering company profiles

 

Chapter 5 – Bioinformatics contracts dealmaking directory

 

5.1. Introduction
5.2. Bioinformatics contracts dealmaking directory

 

Chapter 6 – Bioinformatics dealmaking by technology type

 

Chapter 7 – Partnering resource center

 

7.1. Online partnering
7.2. Partnering events
7.3. Further reading on dealmaking

 

Appendices

 

Appendix 1 – Bioinformatics deals by company A-Z
Appendix 2 – Bioinformatics deals by stage of development
Appendix 3 – Bioinformatics deals by deal type
Appendix 4 – Bioinformatics deals by therapy area
Appendix 5 –Deal type definitions

 

About Wildwood Ventures

 

Current Partnering
Current Agreements
Recent report titles from Current Partnering



Table of figures

 

Figure 1: Bioinformatics partnering since 2014
Figure 2: Active bioinformatics dealmaking activity– 2014 to 2020
Figure 3: Bioinformatics partnering by deal type since 2014
Figure 4: Bioinformatics partnering by disease type since 2014
Figure 5: Bioinformatics deals with a headline value
Figure 6: Bioinformatics deals with an upfront value
Figure 7: Bioinformatics deals with a milestone value
Figure 8: Bioinformatics deals with a royalty rate value
Figure 9: Top bioinformatics deals by value since 2014
Figure 10: Most active bioinformatics dealmakers 2014 to 2020
Figure 11: Online partnering resources
Figure 12: Forthcoming partnering events

 

Pricing options

  • $3,495: single-user
  • $5,245: multi-user
  • $10,495: single site license
  • $17,495: global site license

 

A full explanation of license type definitions can be found here.

 

Our guarantee

 

Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.

 

Delivery Deadline

We guarantee that the report will be sent within the specified delivery times. In the unlikely case of a delay we may offer a partial refund as compensation. (Terms may apply)

 

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

 

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

All card payments are processed by SagePay.

 

Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.

 

Total Trust

Current Partnering is part of Wildwood Ventures Ltd., based in York, United Kingdom. We have been trading successfully online since 2009 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.

1QBit, 2bPrecise, 3B Medical, 3D Signatures, 3D Systems, 3M, 10X Genomics, 14M Genomics, 23andMe, 121nexus, A*STAR Genome Institute of Singapore, A2A Pharmaceuticals, Abarca, Abbott Laboratories, Abbvie, Ab Medica, Abramson Cancer Center, Abyde, Academic Medical Center, Accelerated Enrollment Solutions, Accelq, Accenture, Accuray, AccuWeather, Actigraph, Active Motif, ActX, Acurian, Adapt Analytics, Adaptiiv, Adaptive Biotechnologies, ADAS 3D Medical, Adents, Advaita, Advanced Biological Laboratories, Advanced Guidance Technologies, Advarra, Advaxis, Advocate Health Care, Aether, Aethon, Aetion, Aetna, Aevolve, Agadia Systems, AgaMatrix, AgileBio, Agilent Technologies, Agile Therapeutics, AG Mednet, AiCure, Aiforia Technologies, AirXpanders, AIT Laboratories, AKESOgen, Akili Interactive Labs, Alector, Alexion Pharmaceuticals, Alibaba Health, Alienware, Alit Life Science, Alkahest, Allen Institute for Brain Science, Allergan, Allergan (name changed from Actavis), Alliance for Clinical Research Excellence and Safety (ACRES), Alliance For Clinical Trials In Oncology, Allied-Bristol Life Sciences, Allied Minds, Allotrope Foundation, Allscripts, AllyAlign Health, Almac Group, ALS Association, AltMed Florida, Alvarado Hospital Medical Center, Alzheimer's Drug Discovery Foundation, Amazon Web Services, American Academy of Neurology, American Cancer Society, American Diabetes Association, American Heart Association, American Medical Association, American National Multiple Sclerosis Society, American Physical Therapy Association, American Sleep Apnea Association, American Society of Hematology, American Speech-Language-Hearing Association, American Type Culture Collection (ATCC), American Well, Amerinet, AmerisourceBergen, Amgen, Amplifire, AMRA, Amyris, Ancestry, Andor Technology, Andrew Alliance, Annum Health, ANP Technologies, Anthem, AnthroTronix, AOAExcel, AO Foundation, AppBus, Appian Labs, Appistry, Apple, Applied BioMath, Applied DNA Sciences, Appriss Health, Apricity Health, Aprima Medical Software, Arbor Biotechnologies, ARCA Biopharma, ArcherDX, Ares Genetics, Argent Development Group, Ariana Pharma, ArisGlobal, Aris Global, Arivis, Arm, Armor, ARUP Laboratories, Ascenion, Ascensia Diabetes Care, Asclepia Outsourcing Solutions, Aslan Pharma, Aspen Holding, Astellas Pharma, Astellas Pharma US, AstraZeneca, Asuragen, Athenahealth, Atomwise, ATUM, Audaire Health, Auria Biobank, Autism Learning Partners, Automation Anywhere, Avalere Health, Avera Health, AXA PPP healthcare, Axiom Worldwide, Axway, Ayasdi, Bactevo, Baheal Pharmaceutical, Baptist Health Care, Basepair, Bausch & Lomb, Baxter International, Bayer, Bayer CropScience, Bayer Healthcare, Baylor College of Medicine, BCG Digital Ventures, BC Platforms, Beckman Coulter, Becton Dickinson, BeiGene, BenevolentAI, Berg, BERG Analytics, Berlinger, Bernoulli Health, Bestmed, Be The Match BioTherapies, Beth Israel Deaconess Medical Center, BGI, Bill and Melinda Gates Foundation, Bina Technologies, Bio-Optronics, BioAscent Discovery, BioBeats, BioBright, BioCelerate, BioClinica, BioCorRx, BioDigital, BioDiscovery, Biofors, Bioforum, Biofourmis, Biogen, Biognosys, Biohealth Innovation, Bioinfogate, BioIntelliSense, Biokinetic Europe, BioLizard, Biolog-id, Biological Dynamics, Biomanufacturing Training and Education Center, BioMarin Pharmaceutical, BioMatrix Specialty Pharmacy, Biomedical Advanced Research and Development Authority, Biomedical Systems, bioMerieux, Biomodels, Bionik Laboratories, BioOhio, Biorelate, Biosero, BioSolveIT, Biostem US, Biotechnology Industry Organization, BioTelemetry, BioXcel, Bioz, Blackford, Blackfynn, Blockchain Global, Blockshine Technology, Blue Belt Technologies, BMC Medical, Boehringer Ingelheim, Booz Allen, Boryung Pharmaceutical, BostonGene, Boston Scientific, Boston University, Boston Veterans Affair Research Institute, Box, Bracket, Brain Balance Achievement Centers, BrainLAB, Brains On-Line, Brigham and Women's Hospital, BrightInsight, Bristol-Myers Squibb, BroadcastMed, Broad Institute, Brooks Life Science Systems, Bruker, BSD Medical, BSG Analytics, BSSN Software, BT, Bugworks, BullFrog AI, Buoy Health, BurstIQ, C4X Discovery, CAEK, Caladrius Biosciences, Calico, California Institute of Technology, Cambridge Brain Sciences, Cambridge Cognition, Canada House Wellness Group, Canadian Council, Cancer Research UK, Cannabis OneFive, CannAcubed, Cara Care, Cardiac Insight, CareDox, CareDx, CareFusion, CareJourney, Carepay, CarePayment Technologies, Carestream Health, Caresyntax, CareWire, Caris Life Sciences, Carl Zeiss, Carnegie Mellon University, Cartagenia, CAS, Casetabs, Catabasis Pharmaceuticals, CB2 Insights, CDC Foundation, CDISC, Cedar Gate Technologies, Cedars-Sinai Medical Center, Cegedim, Celemics, Celgene, Cellnetix, Cell Therapy Catapult, Celsion, Centene, Center for Connected Health, Center for Excellence in Engineering Biology, Centers for Disease Control and Prevention, Centogene, Centre for Imaging Technology Commercialization, Centre Leon Berard, Centrexion, CerebraCell, Ceres, CereScan, Cerner, Certainty Health, Certara, CEVA, CHAMPS Oncology, Charles River Laboratories, CheckedUp, ChemAxon, Chemical Abstracts Service (CAS), Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry, Children's Hospital Boston, Children's Hospital Los Angeles, Children's National Health System, Chiltern, Chinese Academy of Sciences, Cholangiocarcinoma Foundation, Christus Health, Chroma Therapeutics, Chugai Pharmaceutical, Cigna Healthcare, Ciitizen, Cilag AG, Cimar, Cincinnati Children’s Hospital Medical Center, Ciox Health, Cirle, CISYS Lifesciences, Clariness, Claritas Genomics, Clarivate Analytics, Cleveland Clinic, Click Therapeutics, Client Outlook, Clinerion, Clinical Research Strategies, ClinicalStudyDataRequest, Clinipace Worldwide, ClinOne, Clinovo, Clinquest, Clinverse Technologies, CluePoints, Coalfire, Code-N, Codexis, Codonics, Cogito, Cognetivity Neurosciences, Cognition Foundry, Cognizant, Cognoa, Cohen Veterans Bioscience, Collaborative Drug Discovery, CollabRx, Collective Medical, Columbia University, Comanche County Memorial Hospital, Combating Terrorism Technical Support Office, Common Sensing, Commonwealth Informatics, Commvault, CompanionDx Reference Lab, Companion Medical, Companion PBx, ComplianceLogix, Comprehend Systems, Compumedics, Concerto HealthAI, Congenica, Consensus Orthopedics, Consortium AI, Contextual Genomics, ContextVision, Corgenix Medical, Corrona, CorTechs Labs, COTA, Courtagen Life Sciences, Covalent Data, Covance, Crescendo Biologics, Cresset, CRF Health, Critical Path Institute (C-Path), Crohn's and Colitis Foundation of America, CrystalGenomics, CTC Clinical Trial, CTI BioPharma, Cumberland Pharmaceuticals, Cure Duchenne, Cure Forward, CureMetrix, Cures Within Reach, Curio Genomics, Curis, Current Partnering, Cynapsus Therapeutics, Cynvenio, Cypher Genomics, Cyrus Biotechnology, Cytapex Bioinformatics, Cytel, Cytobank, CytomX Therapeutics, Cytox, Cyxone, d3 Medicine, Dacadoo, Daiichi Sankyo, Dainippon Sumitomo Pharma, Daktari Diagnostics, Dalhousie University, Dana-Farber Cancer Institute, Danyel Biotech, DarioHealth, Dartmouth College, DarwinHealth, Dascena, Data2Life, DATATRAK International, Datavant, David Snow, DDL Diagnostic Laboratory, DEARhealth, Debiopharm, Deciphex, DecisionQ, Deep Cube, Delivering Scientific Innovation for Autism (DELSIA), Densitas, Dental Assist, Department of Defense, Department of Homeland Security, Department of Veterans Affairs, DePuy, Dermalog, Desktop Genetics, Deutsches Elektronen-Synchrotron, Devana Solutions, DexCom, DiA Imaging Analysis, Diasend, DICOM Grid, Dicom Systems, DigitalizaTXT, Digital Therapeutics Alliance, Diploid, Discovery Life Sciences, Dispersive Technologies, Distributed Bio, Diversified, DJO Global, DNAdigest, DNAmito, DNAnexus, DNA Script, Dnastar, DocuSign, Domainex, DOSIsoft, Dotmatics, Dow AgroSciences, Dow Chemical, DP Clinical, DrFirst, DSG, Duchenne UK, Duke Clinical Research Institute (DCRI), Duke University Medical Center, DynamiCARE, DySIS Medical, e-NIOS, E-Therapeutics, Eagledream Health, Eagle Genomics, eAssist Dental Solutions, EBD Group, EBSCO Information Services, eClinicalHealth, eClinical Insights, Edico Genome, Edison Nation, eemagine, Ehave, EirGen Pharma, Eisai, Elanco, Elastos Foundation, Elation Health, Elekta, Elencee, Eli Lilly, Elligo Health Research, Elsevier, Eltima Software, Elucidata, Elucid Bioimaging, Emdeon, EMD Serono, Emergent BioSolutions, Emocha Mobile Health, Emory Healthcare, EMTensor, Enable Healthcare, Enamine, EnBiotix, Endologix, endpoint Clinical, EndPoint Technologies, ENSCO, Entra Health, EnvoyAI, Enzymatica, EOS Imaging, Epivax, Epoxy, Epsilon, ERS Genomics, ERT, Ethical Oncology Science, Ethicon Endo-Surgery, European Bioinformatics Institute, European Board and College of Obstetrics and Gynaecology, European Innovation Council, European Union, EuroQoL Group, Everledger, Eversana, Evidation Health, Evident Technologies, EvidNet, Evotec, eWellness Healthcare, Exact Imaging, Excelra, Exco InTouch, Exostar, ExplORer Surgical, Expression Analysis, Express Scripts, F-Star, F2G, Fabric Genomics, FDNA, FedCentric Technologies, Feist-Weiller Cancer Center, FEops, Ferring Pharmaceuticals, Fio, Fios Genomics, Firsthand Technology, First Insight, Five Rivers RX, Flagship Biosciences, Flatiron Health, Flo Health, Florence, FlowJo, FlowMetric Life Sciences, Flow Pharma, Fluidigm, Flywheel, FocusScript, Focus Software of Alabama, Food and Drug Administration (FDA), Forty Seven, Forward Advantage, Foundation Fighting Blindness, Foundation for Innovative New Diagnostics, Foundation Medicine, Foundry Health, Fovia Medical, Fraunhofer Institute for Microelectronic Circuits and Systems, Fred & Pamela Buffett Cancer Center, Frederick National Laboratory For Cancer Research, Fred Hutchinson Cancer Research Center, Fresenius Kabi Pharmaceuticals, Fresenius Medical Care, Fudan University, FUJIFILM SonoSite, Fujitsu Laboratories, Fujitsu Laboratories of America, G2 Speech, Gaia BioPharma, Galderma, Galena Biopharma, Garvan Institute of Medical Research, GATC Biotech, GEDmatch, GE Healthcare, Geisinger Health System, Gelesis, GEMCO Medical, GENALICE, Genatak, GenDx, GeneData, GeneDX, GeneInsight, Geneious Biologics, General Electric (GE), Genesis Automation, Genetic Alliance, Genetic Technologies, Geneva University Hospitals, Genewiz, Genfit, GenoLogics, Genome Compiler, GenomeDx, Genome Medical, Genomenext, Genomics, Genomics England, Genomics LTD, Genomoncology, GenoSpace, Genpact, Gentag, George Washington University, Georgia Institute of Technology, Georgia Regents University in Augusta, German Federal State Baden-Wurttemberg, Gestalt Diagnostics, Getinge, Gevity Consulting, Ginkgo BioWorks, GI Partners of Illinois, GlaxoSmithKline, Glencoe Software, Global Clinical Trial Partners, Global Genomics Group, Global Kinetics, Global Record Systems, Glooko, Glow, GlucoMe, Glytec, gMed Canada, GNS Healthcare, goBalto, Goldfinch Bio, GoMo Health, Google, GPC Systems, Graticule, Great Lakes Drug Development, GreenLeaf Genetics, Greenr U, Greenville Health System, Greiner Bio-One, Gritstone Oncology, GRYT Health, GSL Biotech, GTCR Golder Rauner, Guangdong Lewwin Pharmaceutical Research Institute, Halfpenny Technologies, Halo Dx, Halt Medical, Halyard Health, Hamad Medical, Hancom Group, Hanmi Pharmaceutical, Happify Health, HAPPYneuron, Harvard Medical School, Harvard University, Haselmeier, HashedIn, Haystack Bio, hc1.com, HCL Technologies, Healius, Health2Sync, HealthLytix, HealthMyne, HealthPrize Technologies, HealthSteps, HealthTrust, Health Vector, Heart Imaging Technologies, HeartScore, Helix, Hengrui Therapeutics, Henry Schein, Hepregen, HighPoint Solutions, HighRes Biosolutions, Hill-Rom, Hitachi Data Systems, Hitachi High-Technologies Corporation, Hitachi Medical Systems Europe, HIV Resistance Response Database Initiative, Holobiome, Hong Kong Polytechnic University, Horizon Discovery, Howard Hughes Medical Institute (HHMI), HP, HSBlox, HSTpathways, Huawei, HudsonAlpha Institute for Biotechnology, Humana, Human Longevity, Humboldt-Innovation, HuminTec, Hygieia, IBA, IBM, IBM Watson Health, iCAD, Icahn School of Medicine at Mount Sinai, Icometrix, Icon, IDBS, Idengene, ID Genomics, IDnow, IEH Laboratories & Consulting Group, iFLYTEK, Igenbio, Illumina, ILUM Health Solutions, ImageIQ, Imagene Labs, Imagia, Imbio, ImmersiveTouch, Immucor, Immuneering, Immunexpress, Immunocore, iMPak Health, ImpediMed, Imperial College London, ImplantBase, Imprimis Pharmaceuticals, Imprivata, IMS Health, In-Q-Tel, INC Research, Incyte, Indegene Lifesystems, Indiana University, Indivumed, Infobip, InfoChem, Infor, inHEART, InnerOptic Technology, InnerScope Hearing Technologies, InnoCentive, Innoplexus, Innovate UK, Innovation Health, Innovative Medicines Initiative (IMI), Inovalon, Inscopix, Inserm, Inserm Transfert, Insight Genetics, InsightRX, Insilico, Instem, Institute for Systems Biology, Institute of Bioinformatics, Insulet, Intabio, Integra LifeSciences, Inteliquet, Intellegens, Intelligence Advanced Research Projects Activity (IARPA), Intelliware Development, Interface People, International Progressive MS Alliance, InterSystems, Intertrust, InTouch Health, Intrexon, Intuitive Surgical, InvenSense, Invenshure, inviCRO, Invitae, InVivo, InVivoScribe, IQVIA, iReceptor Plus, IrisVision, Ironshore Pharmaceuticals, Ironwood Pharmaceuticals, iSage Rx, ISDIN, iSpecimen, Iteris, IXICO, Janssen Biotech, Janssen Diagnostics, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, Japan Medical Dynamic Marketing, Japan Tobacco, JAYEX Technology, J Craig Venter Institute, JCR Pharmaceuticals, Jewish General Hospital, Jiangsu Provincial Institute of Materia Medica, John Hopkins University School of Medicines, Johns Hopkins Medicine (JHM), Johns Hopkins University, Johnson & Johnson, Johnson & Johnson Consumer Companies, Johnson & Johnson Innovation, Jointpoint, Juniper Investment Company, Juno Biomedical, Juvenile Diabetes Research Foundation, Jvion, Kailos Genetics, Kaiser Permanente, Kantar Health, karmadata, Karolinska Institute, Karolinska University Hospital, Karyopharm Therapeutics, Kavli Foundation, Keck School of Medicine of USC, Kings College London, Kite Pharma, Kitware Partner, Klue, Kneat, Knight Cancer Institute, Kois Center, KOL Bio Medical Instruments, Komodo Health, Koneksa Health, KromaTiD, Kyoto University, Labcyte, labfolder, Laboratory Corporation of America, LabStyle Innovations, LabTwin, Labworks, Laerdal Medical, La Jolla Institute for Allergy & Immunology, Lakeland Health, LALREAN, LCG, Learnsoft, Lee Moffitt Cancer Center, Leica Biosystems, Leidos, Leidos Holdings, Lesaffre, Leukemia & Lymphoma Society, Levelblox, Lieber Institute, Life Image, LifeMap Sciences, LifeNome, LifeOmic, LifeScan, LifeServe Blood Center, Limbix, Lineagen, Linguamatics, LiquidHub, Litesprite, Livongo Health, LLamasoft, Lockheed Martin, LogicNets, Logic PD, London Medical Databases, Lord Global, LSPediA, Luminostics, Lundbeck, Lupus Foundation of America (LFA), Luxembourg Institute of Health, Luxoft, Lyphe Group, LZ Lifescience, M*Modal, M2Gen, Maccabi Healthcare Services, Maccura Biotechnology, Mach7 Technologies, Macrogen, Magic Leap, MAGNA Pharmaceuticals, Management Science Associates, Mapi, Marubun, Maryland State Medical Society, Masimo, Massachusetts General Hospital, Massachusetts Institute of Technology, Mass Consortium, MasterControl, Materialise, Max-Planck, Mayo Clinic, Mazor Robotics, MC10, McGill University, McKenzie Management, McKesson, MD Anderson Cancer Center, MDClone, MDdatacor, MDL Information Systems, Med-Pass, Medable, Medbanks Network Technology, MedChain, MedCom, Medeor Therapeutics, MedGenome, Medial, MEDIAN Technologies, Medibio, Medicago, Medical Research Council, Medical Technology Enterprise Consortium, Medical University of Bialystok, Medical University of Innsbruck, Medicollector, Medidata Solutions, Medipath, MediSafe, MediSapiens, Meditech, MediTechnix, Medivir, Medivo, Mediware Information Systems, Medley Genomics, Medline Industries, MedNet Solutions, MedOne, Medpace, MedPro Systems, Medtronic, MedyMatch, Meiogenix, Melax Technologies, Memorial Hermann Health System, Memorial Sloan Kettering Cancer Center, Mercachem, Merck and Co, Merck KGaA, Mercy Hospital, Merge Healthcare, Merial, Merqurio, Merz, Mestrelab Research, Metabolon, Metanome, Metaoptima Technology, Metrics, Metro Health, Mevion Medical Systems, Michael J Fox Foundation, MicroHealth, Microsoft, Midway Dental Supply, MilliporeSigma, MIM Software, MindPeak, Mind The Graph, Ministry of Health (Algeria), Miracle-Ear, Mitsubishi Tanabe Pharma, Molecular Health, Molecular Pathology Laboratory Network, Molplex Pharmaceuticals, Monsanto, Montefiore Health System, MORE Health, Morphic Therapeutic, MorphoSys, Mount Sinai Health System, MPECT, MRI Interventions, MuleSoft, Munich Leukemia Laboratory, Murdoch Childrens Research Institute, MVI Health, MWI Animal Health, mySugr, myTomorrows, MyVytalics, N-of-One, NABsys, Nancy and Stephen Grand Israel National Center for Personalized Medicine, Nano-X Imaging, Nano3D Biosciences, Nano Global, NantHealth, NantOmics, Nashville Biosciences, National Cancer Institute, National Center for Genome Resources, National Center for Tumor Diseases, National Healthcare Services (NHS), National Health Service, National Heart, Lung and Blood Institute, National Hemophilia Foundation, National Human Genome Research Institute, National Institute for Health Research (NIHR), National Institute of Allergy and Infectious Diseases, National Institute of Mental Health, National Institute of Neurological Disorders and Stroke, National Institute of Standards and Technology, National Institute on Aging, National Institute on Deafness and Other Communication Disorders, National Institute on Drug Abuse (NIDA), National Institutes of Health, National Science Foundation, Nationwide Children’s Hospital, Nautilus, Navican, Navigating Cancer, Navitas, Nebula Genomics, NEC, Neiman Institute, Nestle, Nestle Health Science, Netherlands Cancer Institute, NetScientific, NeuroCog Trials, NeuroLex Laboratories, NeuroLogica, NeuroScience Associates, NeuroTracker, Newborn Screening Ontario, NewCrop, New England Biolabs, New York Genome Center (NYGC), New York State Department of Health, New York University, New York University School of Medicine, NextCODE Health, NextGate, Next Gen Diagnostics, NextGen Partners, NextMove Software, Nexus Data Services, Nico, Nobelpharma, NOCTEM, Noom, Northern Arizona Healthcare, Northern California Institute for Research and Education, Northrop Grumman, Northwell Health, Northwestern University, North Zealand University Hospital, Novant Health, Novartis, Novaseek Research, Novatek International, Novigenix, Noviosense, Novo Nordisk, Novopath, Novozymes, Nrgene, NTT Medical Center Tokyo, Nuance Healthcare, Nucleobase, Numerate, Numira Biosciences, Nuritas, Nvidia, NXT-ID, Nyansa, OARO, OBERD, Obsidian Therapeutics, Ochsner Health System, OKKO Health, Olympus, Olympus Respiratory America, Omada Health, Omicia, Omnicell, OmniComm Systems, Omnyx, OncoImmunity, OncologyInformationService, Oncology Pharma, Oncology Research Information Exchange Network, OncoMyx Therapeutics, Oncora Medical, OnDeckBiotech, Onduo, One Codex, One Drop, OneMedNet, Oneome, OnMed, Ono Pharmaceutical, Onramp Bioinformatics, ON Semiconductor, Ontario Brain Institute (OBI), Open Commons Consortium, OpenEye Scientific Software, OpGen, Opisafe, OPKO Health, Optasia Medical, Optibrand, Optibrium, OptimizeRx, Oracle Health Sciences, Orbita, Orbus Therapeutics, Oregon Health Sciences University, Orexo, ORHub, Origin Agritech, Orion, OrthoAccel Technologies, OSE Immunotherapeutics, Ospedale Pediatrico Bambino Gesu, Oticon, Otsuka, Otsuka America Pharmaceutical, OTTR, Ovation Life Sciences, Owkin, Oxford BioMedica, Oxford Biomedical Research Centre, Oxford Genetics, Oxford University Hospitals NHS Trust, OxyPharma, PaceMate, Pacific BioScience of California, Pacific Northwest National Laboratory, Pacific Northwest Research Institute, Paidion Research, Paige, Palabra, Palantir, Paradigm, Parent Project Muscular Dystrophy, Parexel, Parker Hannifin, Particle Measuring Systems, PARx Solutions, PathAI, Pathcore, Pathway Health, PatientFi, Patient Genesis, Patient identification Platform, PatientLink Enterprises, PDS Life Sciences, Peakdale Molecular, PEAR Therapeutics, Peek Vision, Penn Medicine, Pennsylvania Department of Health, Pensiamo, Pentax, Penumbra, PeptiDream, PercayAI, Performance Livestock Analytics, PerformRx, PeriGen, PerkinElmer, Personal Genome Diagnostics, Personalis, Pertexa, PetaGene, Petriage, Pfizer, PharmaMar, Pharmatech, Phenomics Health, Philips, Phlexglobal, Phoenix Children’s Hospital, Photometrics, PHT, Physiomics, PhysIQ, PierianDx, Pinnacle Clinical Research Center, Pioneer Solution, Pixvana, Planbox, Plecosystems, Plexus, Plume Labs, Plyzer Technologies, PMG Research, Pocket Nurse, Poitiers University, PositiveID, PPD, Precera Bioscience, Precise Biometrics, Premier Biosoft International, Premier Health Group, Premier Inc, PrescribeWellness, Pressure BioSciences, PreventionGenetics, Prime Therapeutics, Primetime Medical Software, Prisym ID, ProcessPro, Procter & Gamble, Profil Institute for Clinical Research, Progenitor Cell Therapy, Prognos, ProHEALTH Medical Management, Promenade Software, Prometheus Laboratories, Proove Biosciences, Prophase Labs, Protagen, Protein Metrics, Proton Therapy, Proximagen Group, Proximo Medical, Pulse Infoframe, Q-State Biosciences, Q2 Solutions, Q2i, Qiagen, QPharma, QuadMed, Qualcomm, Qualcomm Life, QuantalRF, Quartesian, QubeChain, Quest Diagnostics, Quicksilver Scientific, Quintiles, Quintiles IMS Holdings, R1 RCM, R3, Radboud University Nijmegen Medical Centre, Radformation, Radialogica, RadNet, Rational Surgical Solutions, RaySearch Laboratories, RCT Logic, Redesign Science, Red Hat, Redox, Regeneron Pharmaceuticals, Regenstrief Institute, RelianceHMO, Reliq Health, Reltio, Rensselaer Polytechnic Institute, Repositive, Repositrak, Rescon Technologies, Research Institute of McGill University Health Centre (RI MUHC), ResearchMatch, Resmed, Resolution Bioscience, Respicardia, Response Genetics, Revon Systems, Ribera Solutions, Riffyn, Right Submission, Rimidi, Rimsys, Riverside Research, Robert Wood Johnson Foundation, Roche, Rock-Pond, Ro Invest, RORZE Lifescience, Rosetta Genomics, Roswell Biotechnologies, Royal Perth Hospital, Royal Philips Electronics, RQI Partners, RTI International, Rubicon Genomics, Rush University Medical Center, RxAdvance, RxMx, Rymedi, S2 Interactive, Saama, Sage Bionetworks, Sage Therapeutics, Salient Surgical Technologies, Sample6, Samsung Biologics, Samsung Electronics, Sanford Burnham Institute, Sanguine, Sanofi, Sanofi Chimie, San Raffaele Hospital, Sapio Sciences, Sarah Cannon Research Institute, Sartorius, Savonix, Schrodinger, Science 37, Science Exchange, Science for Life Laboratory, Sciex, Scilligence, Scripps Research Institute, SCWorx, Seattle Children's Hospital, Second Genome, Sectra, Securecell, Seizure Tracker, Selah Genomics, Selcia, Self Care Catalysts, Sempre Health, Senescence Life Sciences, Sensiotec, Sentieon, Seoul National University, Seqster, Sequenom, Seracare Life Sciences, Sernova, Seven Bridges Genomics, Seven Bridges Genomics UK, Shanghai Institute of Materia Medica, Shanghai Mental Health Center, ShanghaiTech University, Sheikh Zayed Institute for Pediatric Surgical Innovation, Shionogi, Shire Pharmaceuticals, Shivom, SHYFT Analytics, Sidney Kimmel Cancer Center, Siemens Healthcare, Siemens Healthineers, Sight Diagnostics, Sigma-Aldrich, Signant Health, Signix, SilverCloud Health, Simbec Research, Simbiot, Simplyfeye, Simulations Plus, Sirenas, SirenMD, Sirona Genomics, Sisense, Sixense Enterprises, Skyland Analytics, SmartAction, Smith & Nephew, Social Reality, Society of Gynecologic Oncology, Socionext, SOINN, SolveBio, Sonacare Medical, SonarMD, Sonic Healthcare, SonoSim, Sonova, Sophia Genetics, Sorin Group, Sotera Wireless, Spectrum Health, Spheryx, STADA Arzneimittel, StageDotO, Standigm, Stanford University, Stanford University School of Medicine, StayinFront, Stem Cell Theranostics, Stereotaxis, Stonehaven Incubate, StoryCorps, Strand Life Sciences, Stratasys, Straumann, Striiv, Stryker, Supernus Pharmaceuticals, Sure med Compliance, Surfacide, Surgical Notes, Susan G. Komen for the Cure, Syapse, SymBio Pharmaceuticals, Syn-The-All Pharmaceutical, Synaptive Medical, Synbio, Syneos Health, Synergistix, Synexus, Syngenta, Synopsis Healthcare, Synthace, SysFera, SystemOne, T3 Labs, Takeda America Holdings, Takeda Pharmaceutical, Talis Biomedical, Tandem Diabetes Care, TapGenes, TATAA Biocenter, TB Alliance, TearLab, Tebu-Bio, Technology University Dresden, Telcare, Telos Discovery Systems, Temis, Tempus, Tencent Holdings, Tenet Healthcare, TenX Biopharma, Terso Solutions, Terumo Cardiovascular Systems, Terveystalo, TeselaGen, TesoRx Pharma, TestAnalytika, TetraScience, Teva Pharmaceutical Industries, TFS International, The Consortium of Rheumatology Researchers of North America, Theorem Clinical Research, TheraCann International Benchmark, Thermo Fisher Scientific, The University of Chicago Medicine, Thomson Reuters, ThoughtWire, Three S Japan, Tidepool, Tigerspike, Tilak Healthcare, Tissue Analytics, Titian Software, TME Research, Tobii Technology, TogetherMD, Toshiba, Touch Surgery, Toulouse University Hospital, Trakcel, TransCelerate BioPharma, Translational Drug Development, Translational Software, Transmed Systems, TransPerfect Life Sciences, TransPerfect Medical Device Solutions, Transpire, TrialAssure, Trialbee, TrialSpark, TriNetX, Trio Healthcare, Triumph Research Intelligence, Triventis, Tromp Medical, TSRL, Tucker Medical, Tute Genomics, Twist Bioscience, twoXAR, Ubic, Ubirch, UCB, UK Government, uLab Systems, UL EduNeering, uMotif, Unified Women's Clinical Research, Unissant, United States Military Cancer Institute, UniteOR, UnityPoint Health, Universite Laval, University College London, University Hospitals Case Medical Center, University of Arizona, University of Bristol, University of California, San Diego, University of California Berkeley, University of California Los Angeles, University of California San Francisco, University of California Santa Cruz, University of Cambridge, University of Chicago, University of Dundee, University of Hong Kong, University of Leeds, University of Liverpool, University of Manchester, University of Maryland Baltimore, University of Maryland School of Medicine, University of Miami, University of Michigan, University of Michigan Medical School, University of Montreal, University of Nagasaki, University of Nebraska, University of New South Wales, University of Oxford, University of Pittsburgh, University of Quebec, University of Rhode Island, University of Rochester, University of Sherbrooke, University of Southern California, University of Toronto, University of Utah, University of Vermont, University of Virginia, University of Washington, University of Zurich, UPMC, Upside Health, UpToDate, US Army, US Department of Veteran Affairs, US Government, US Oncology, US Vision, UV Partners, Valeant Pharmaceuticals, ValGenesis, Validic, VA Medical Center (VAMC), Vanderbilt-Ingram Cancer Center, Vanderbilt University, Vanguard Scientific Systems, Varian Medical Systems, Vcpi, Veeva Systems, Velocity Medical Solutions, Velos, Verady, Verana Health, Verb Surgical, Verge Genomics, Verily, Veristat, VeriTeQ, Verix, Vernalis, Verogen, Vertex Pharmaceuticals, Veta Health, VetNOW, VIB, Victorian Clinical Genetics Services, Vida Diagnostics, Vidscrip, Vince & Associates Clinical Research, Vir Biotechnology, Viroclinics Biosciences, Virta Health, Visiopharm, VisiQuate, Visotec, ViS Research Institute, Vistinct, VisualDx, Visual Medica, Vital Connect, VitalHub, Vital Images, VitalTech, Vitaphone E-Health Solutions, Vitrisa Therapeutics, Vitruvian Networks, Vivante Health, Vivid Medical, Viviphi, VivoSense, Vivus, Viz.ai, Vizient, Vodafone, Volk Optical, Volpara Solutions, Voluntis, Vuemed, WaferGen Biosystems, Ward Medication Management, Warp Drive Bio, Warrior Centric Health, Washington University in St Louis, Waters Corporation, Weill Cornell Medical College, Weizmann Institute, WekaIO, Wellcome Trust, Wellcome Trust Sanger Institute, WellDoc, WellDyne, WellStar Health System, Wellthy Therapeutics, West Pharmaceutical Services, Whiterabbit, Widler & Schiemann, WinterLight Labs, Wipro, WIRB-Copernicus Group, Woom, World Health Organization, World Vision India, Wuxi Apptec Laboratory Services, WuXi NextCODE Genomics, Wyss Institute, xD Bio, Xentech, Xpressomics, XRHealth, Xybion, XynManagement, Yale School of Medicine, Yale University, Yellowbrick, York Instruments, YPrime, Zahra Holdings, ZappRx, Zastra Innovations, Zebra Medical Vision, Zebra technologies, Ziehm Imaging, Zimmer Biomet, Zingbox, ZYUS Life Sciences

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• CRADA
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.